Nader said at the last webinar that we had an addi
Post# of 142640
Prior to this approved “extension” it was said we would only need 70 people to achieve better efficacy and P-value. Since Nader said we had 55 in the last call. I am hoping by now we have the 70 patients. Seems reasonable to assume an additional 15 patients.
Nader also listed 3 ways for the quickest EUA and listed these additional patients. So I am assuming the extension to our CD-12 trial is the quickest way to EUA as Nader also stated.
If I am incorrect in calling it an extension and that is your issue. We have FDA approved “time” to continue to collect additional patients in our CD-12 protocol. Is this what you dispute? If it is... then you missed a bunch of talking points that have been brought up since we released the original trial results.